Tuesday Night Film
The All Souls Documentary Series shows a film at 7p.m. each Tuesday. Our series emphasizes quality films with social justice themes that rarely make it to conventional movie theaters. Carolyn Macdonald long time coordinator of our locally recognized Forum lecture series facilitates this acclaimed documentary series in concert with a group of passionate volunteers.
Each screening is followed by a lively facilitated discussion. Admission is free and popcorn and snacks are available for a very nominal fee. No tickets or reservations are needed. The public is welcome. Join us!
All Souls Documentary Film Series
Each documentary is followed by a facilitated discussion.
Admission is free, with donations appreciated.
January 2010 Schudule
7:00 pm Tuesday, January 12
We Are Dad
Michael Horvat • 2005 • 71 minutes
A gay couple who are pediatric AIDS nurses become foster parents to infants who are HIV positive. The film chronicles the family’s struggles from the early days of the AIDS pandemic until the oldest are teenagers. However, they have not been allowed to adopt any of the children because of Florida’s discriminatory ban on gay adoption.
7:00 pm Tuesday, January 19
Eyes on the Prize: Bridge to Freedom
Henry Hampton • 1987 • 60 minutes
This is the seventh episode of the critically acclaimed 14-part series on civil rights in American
during the period 1954-1984. In December 1964 Martin Luther King Jr. at age 35 becomes the
youngest person to receive the Nobel Peace Prize. A decade of lessons is applied in the march
from Selma to Montgomery, Alabama. A major victory is won when the federal Voting Rights Bill
passes, but civil rights leaders know they have new challenges ahead.
7:00 pm Tuesday, January 26
Health for Sale
Michele Mellara and Alessandro Rossi • 2007 • 53 minutes
Are the world's largest drug companies, paradoxically, major obstacles to making a healthier
world? The film focuses on Big Pharma, the ten largest pharmaceutical makers, who account for
500 billion dollars of world health spending a year. Officials from all sides debate the impact of
drug companies' patenting, "intellectual property," pricing and new product development
strategies on global public health.